CFAP36

Across TCGA pan-cancer cohorts, CFAP36 mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated CFAP36 data layer compared with 26 for mass-spec protein and 1 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher CFAP36 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated CFAP36 expression acts as an unfavorable survival marker.

CCRCC, HNSC, and PDAC are the cancer types where CFAP36 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	DFS	Tertile	All	0.533	0.901	<.001	41	view →
HNSC	OS	Tertile	All	0.318	1.000	.014	18	view →
PDAC	OS	Median	All	0.455	0.607	.012	14	view →
LSCC	DFS	Median	II,III,IV	0.451	0.877	.044	1	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

CFAP36–CCRCC (DFS)

Open the CCRCC breakdown →